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Rapid atria, pcing il * “lph, *ea”iq”s md unrn Ihe 
therapy Of choice to *ermin;nr *triaJ ttLlt,er in p*tien,o. 
However, inlempth al atrist Rulter by rapid *trial 
pacing imy not *hays produce sinw rhythm, but rather 
may ruutt in atriat hbrtllslion. Twdve patients with rpon. 
taneols atrial flutter lb*, had ken pros n, for 2-24 h wew 
studied to BSSIS~ the &ioey cd aMat paring, atone and in 
combination with procaimmida, to romrert at&at Aotter to 
normal sinus rhythm. Rapid atria, pacing for 215 I lrorn 
selected atrial rites Y wkctal paring rate5 were perlormed 
during a,rY RU(ter. Tk initial pacing rate was always at a 
cyete length 10 Ins shm,er ,hEm the atria, R”,,s Cl& 
leogth. If atrinl flutts persisted after cersatton of pacing, it 
was rqmted at progressively sluater cycle lengths until 
either a rate of 4lM kaWmin was acbirved or atrial 
TM patimts r&sod procatnmide and 9 afthn 10 had 
tongtblnblgor,be atrtat R”ttwydele”gtb by a mea” a168 
ms (I patient continued to bare atrial fibrillationI. Then, 
using the same atrial pacing p*torat, high right atria, 
pacing atone at a mean cycle ltngtil of 127 ml interrupted 
atrial Rutter in 311 tbw ~~;timb, re,urtietbeir rbvthm to 
Rapid and e&live treatment ofatrial flutter to restore rinus 
rhythm can be a difficult clinical problem. Antiarrhylbmic 
drug therapy alone is frequenrly ineffective in terminating 
atrial flutter and may be quite time consuming. Dxecr 
current cardioverrion is usually effective. but it carries 
certain risks and may be undesirable (l-3). Rapid atrial 
pacing is one possible choice for treatment to interrupt artal 
flutter and can be perfonncd safely using a variely of 
methods (S-7). In some patients, for example. those who 
have received a large amount of a digitalis preparation or 
those who have chronic obstructive pulmonary disease for 
whom sedation is a risk. pacing may be the desirable form of 
therapy (53.91. It is the trealment ofchoice in some patients, 
for example. those who have undergone open heart surgery 
and have temporary auial epicardial electmdes in place 
(S.li%i?l. 
Rapid atrial pacingalone has the capability ofintermpling 
atrial flutter. but conversmn IO atrial fibrillation rather than 
sinus rhythm may result (>191. Although atrial fibnllarion 
may be transient. converting spontaneously to sinus rhythm. 
it may revert to atrial flutter or i. xy purist (5-7.0). Thus, if 
sinus rhylhm iq the desired end point. direct current cardie 
version or antiarrhythmic drug therapy may still be required 
for some patients after rapid atrial pacing of atrial Rulter. 
Therefore. any method that would improve the likelihood 
rbat rapid amal pacing would successfully intermpt arrial 
flutter and restore sinus rhythm would be desirable. 
Previous retrospective studies (7.13-17.19) of atrial pat- 
ing IO mtermpt atrial flutter have included patients receiving 
a type IA antiarrhythmic agent. Our examination of these 
previous studies suggests that such agents may have been 
usefu adjuncts for successful alrial pacing intcrmpricm of 
arrial flutter with return to sinus rhythm. One pmswtive 
study (?I) mdiwted tha, diropyramide was helpful in restor- 
ing sinus rhythm when used with rapid alrial pacing to 
interrupt atrial Rotter. However, the latter study probably 
was not a fail test of the efdcacy of the mpid at&l pacing 
technique when used without drug therapy. In this report, 
w present the results of a prospective study designed to test 
the hypothecis that procainamide. a tyw IA antiarrhythmic 
agent, would augment the et%cacy of rapid atria1 pacing to 
restore sinus rhythm in patients with atria1 flutter. 
Methods 
Study patientr (Table 1). Twelve consecutive patients. I I 
male and I female, aged 14 to 16 years (mean 55). each with 
sponlaneous atrial flutter for >24 h associated with stable 
hemodynamics and a controlled ventricular response rate. 
were studied. The associated underlying clinical slate var. 
ied. but no patientc were in the immediate period after open 
heart surgery. Eight of the I2 patients studied had a previous 
2 or 3 day trial of an orally administered conventional type 
IA antiarrhythmic agent Iquinidine. procsinamide or disopy- 
ramidcl without reversion of the atriai flutter to sinus 
rhythm. 
Electrophysiolade study. Afler informed consent was ob- 
tained, each patient was itudxd in the nonsedated. postab- 
sorptive state usmg standard electrophy+alogic techniques 
during cardiac catheteriration. All palients were receiving 
algoxin. but olherantiarrhythm~c agents wcrc withheld for at 
IXSI 5 half-lives before study. Multipolar catheter electrodes 
were advanced to selected atrial sites !the high right atrium, 
the low right atrium, the His bundle and the coronary sinus) 
and used for pacing and recording. The His bundle catheter 
was positioned at a relatively proximal location to permit 
recording of atrial electrograms from the atrioventriculsr 
(AV) junction. Bipolar electrqrams were recorded between 
a bandpass of IO to 500 Hz. Electrocardiographic (ECGl 
leads I, 11,111 and VI as well as all bipolar atriai electrograms 
were recorded simultaneously on photographic paper at a 
speed of IW mm/s using an Electronics-for-Medicine VRlh 
switched-beam oscilloscopic recorder. All data were also 
recorded on a Honeywell Sf,OOC FM tape recorder for 
wbsequent data playback and analysis. 
Rapid atrial pacing pmtow!. During atrial flutter, bipolar 
atria1 pacing at;wice the stimulus threshold was performed 
using a Medtronic 1349A pmgrammahle stimulator. Atrial 
pacing was initiated at a cycle length IO ms shorter than the 
spontaneous atrial flutter cycle length. After establishing 
atria1 cardore bv demonstratinp. acceleration of all recorded 
atrial el&trogr&ns to the pa&g rate, atrial pacing we.6 
continued in all @dents for 2 I5 s. On cessation of pacing. if 
the atrial flutter persisted, the pacing cycle length was 
decreased by 10 ms (eight patients) or the pacing rate was 
increased by IO beatslmin (four patients). and pacing was 
again performed in the same manner. In all patients. in an 
effort to avoid precipitation of atrial Abrillation (5.10.1 I). 
atrial pacing was never performed at a rate >400 beatslmin. 
If atrial pacing induced atrial librilhtion (transient or SW 
mined) a5 a result of pacing at a rate <4W beatsimin. more 
rapid pacing was not performed from this atrital we. 
In ofI poricnrs. winl plrcinp wus initially pcrformcd jrm 
rhr high right orriwn. If atritd Rurter was not interrupted 
during pacing from this site. pacing WE performed from the 
other atrial sites. Five patients had rapid pacing performed 
from the high right atrium and coronary sinus (left atrium1 
and four patients had pacing performed from the high right 
rtrium. coronary smos and a low right atrml iilc. If awd 
flutter persisted or if atrial fibrilktion was precipitated. 
procainamide was then infused intravenously at a dote of 
1,0&l mg over 20 min (six patients) or 5Ml mg over 10 mm 
(four patients). After procainamide infusion. rapid atna, 
pacing was again performed using the previously described 
pacing protocol in all Qafienfs in whom atrial fluncr was 
present. 
During atrial flutter in all patienls, recorded atrial elec- 
twaam met the criteria for atrial flutter based on electro- 
graphic recordings (22) and the 12 lead ECG demonstrated 
easily discernible Ruiter waw IFk. I). The mean atrial 
cycl; length was 233 ? 26 ins (r&e 205 lo 290). and the 
mean ventricular response rate was <IS0 beatslmin. 
Rapid atria, pacing b&we pmcainamide adminislr&n. 
Using the pacing protocol described. ot least one of the 
criteria to establish the presence of transienl entrainment 
(23-26) was demonstrated in every patient during atrial 
pacing of atria1 flutter. Howeve:. in only 2 of the I2 &nts 
studied (Cases I and 3) was atrial Autler converted to sin”> 
rhythm in the absence of prwainamide. In one of those Iwo 
patienls (Case I: atrial flutter cycle length 20s ms). atria, 
pacing at a cycle length of 150 ms prectpirated atria, fib& 
li~lwn (271. Th,i !xlcr rhythm cpanlzneou4y revened to 
:alrt:d flutter wthm a few minutei. but then raoid oacine at 
ihc wnc cycle length again restored sinus rhythm. In three 
qrhcr ~iitna ((_a~\ 5, 7 and 9). wslaincd atrial fibrillstion 
wit\ QrccipiMed by rapid atrial pacing (Fig. ?,. In the 
rcm:Goint wven patients (mean atria, flutter lenah 241 r 29 
~n%l. r.ipid .ilrLl pacing (mean cycle length 177 ? I, rns) 
cauwi silhcr Irdn,ierd atrial fibrillation (Fig. 3) or a more 
wid form of a:rkal flutter (type :I) 122) with subseouem 
ream to rhe previollr alria, R&r. oi 3 paced atria, mte of 
WO bevrrmm was achieved. 
Admini~ration of pnrsinnmide. After rapid pacing, pro- 
c:dnamidc was administered intravenously per protocol 
wthool advene eRccrs in the IO palienrs (3 patients with 
atrral Rbrdlation and 7 wth atna, flutter). Panem 5 continued 
IO hnve arral fibrillation despite procomamide administn- 
bon w !bal dwct current cardiovcrnion had to be performed 
on the next day to restore sinus rhythm. Patient 7 had atrial 
Rbrillarion induced during atrial pacing before procainamide 
admimrtraiun: atrial flutter at a ~Iower cycle length (285 ms) 
resumed during prorainomide infusion. Patient 9 hod _‘;ial 
fibrdlarlon Induced during npid atrial pacing before pw 
cainamide admmistration: sinus rhythm &sued during bru 
cainamide administration. In this patient. rapid atrial pacing 
at 300 bealslmin rcinduccd atrial Autrcr with a similar rela- 
tive atrial actiwion sequence ldetermmed from the electro- 
grams recorded from all electrode recording sites) and with 
an atrial Rutlcr wave configuration in the ECG similar 10 that 
during the previous sponlaneour atrial flutter. The laller two 
patients and Ihe seven QatientS whose rhythm remained 
anal flutter after Ihe initial rapid atrial pacing protocol 
constituted the populalian studied after procainamide ad- 
mimstrahon. 
The onset ot rapid high right atnal pacmg II demonstrated m panol 
A. Atrial fibtillai:m is present transiently after cessation of pacing 
,panet B,, foilowrd by reiumptio” ofthe IBme atria, flutter present 
before rapi atria, pacing (panel Cl. Panels A. B and C are contin- 
uous. HBP = proximal His bundle; HBd = distal His bundle: athcr 
abbreviations as m Figures I and 2. See text for dircurrion. 
nil ~UIIIIPIIIS. the mean duration increasing 68 ms from 231 to 
305 ms, but the relative atrial activation sequence and the 
atrial flutter wave configuration did not change as a result of 
procainamide administration (Fig. 4Al. No patient had upon- 
~anews conversion of atria! flutter to sinus rhythm during or 
after intravenous procainamide administration alone. 
Rapid atrial pacing after procainamido admlnistrution. 
After procainamide administration. rapid atrial pacing was 
initiated at a slower rate than before procainamide adminis- 
tration because of the slower spontaneous rate of the atrial 
Auttcr. but the pacing protocol remained the same. No 
adverse effects from the drug administration were observed. 
In all nine p&nts, rapid pacing during atrial flutter was 
performed from only one atrial site (the high right atrium) 
because pacing from this site now successfully interrupted 
atrial flutter and restored normal sinus rhythm (Fig. 48). In 
five at thcsc nine patients, nkr cessation of rapid atrial 
pacing, a transitional rapid rhythm of three to six beats of 
variable cycle length and irregular electrographic configura- 
tion--different from the soantaneaus atrial flutter-ensued 
before sinus rhythm was restored (Fig. 51. In three patients, 
the first spontaneous rhythm after cessation of rapid atrial 
pacing was sinus rhythm (Fig. 61. In the one other patient 
(Case IO), after cessation of atrial pacing. a slow ectopic 
atrial tachycardia (cycle length 440 m.) vnr present. Atrial 
pacing at a cycle length of 265 ms interropted this rhythm, 
with sinus rhythm heiy prcasnt when pacing was stopped. 
After proeainamide administration. the mean attird pacing 
cycle length at which interruption of atrial flutter occurred 
was 221 tns (range 172 to 340). Pacing at these cycle lengths 
before procainamide administmtion, when it could even be 
Figure 4. Patient 6. SPme recordmgs a, in Figure 3. panel A, Atrial 
Rutter is stilt present after procainamide infusion. but the rate is 
much sloaertcyck length 3M)msl. The electragraphic configuration 
and relative atrial activation sequence are the SWIK as they were 
before procainamide infusion (Fig. 3). pand 8. After proainamide 
infusion. rapid high right atria! pacing at a slower cycle length t?W 
ins) interrupts atrial Rutter with resumption of sinus rhythm. Abbre- 
viadons as in Figures i and 3. Set text for diacu~ion. 
accomplished, failed to interrupt atrial flutter. In three of 
these patients (Cases 6, IO and i I). rhe cycle length of thcii 
atrial flutter before procainamide administration was shorter 
than the pacing cycle length required for ixerruption of 
atrial flutter in the presence ofprocainamide. In two of these 
nine patients (Cases S and 9,. we had the opportunity to 
retest the efficacy of rapid atrial pacing to convert atrial 
Rutter to sinus rhythm because each had recurrent atrial 
flutter. For both patients. conversion of amal Autter to sinus 
rhythm only occurred after rapid atrial pacing was combined 
with intravenous procainamide therapy. 
Discussion 
Role of procainamide in augmentine the eRicacy of rapid 
atrial peeing. These data demonstrate m a prospectivr maa- 
ner that procainamide augmented the efficacy of rapid atrial 
pacing to interrupt spontaneous atrial flutter and restore 
normal sinus rhythm in cur cohort of patients. Furthemtore. 
there was no adverse effects from drug administration. One 
previous prospective study 121) that employed mtmve~~us 
disopwmide therapy concluded that disopyramide helped 10 
produce sinus rhythm after atrial pacing interruption of in- 
duced atria1 flutter. However. in that study, the three pacing 
rates used to attempt intermplion of atria1 flutter were likely 
not a fair test of the pacing technique almte. One of ;he three 
rates (IO beats/mitt laster than the atrial flutter rate) was 
virtually certain only to emain the atrial tlutter trmsiently: 
one r.ate (100 beats/min faster !han the atrial flutter rate) was 
verv likelv to wecioitate atrial fibrillation and one iate 150 
be&nin~fart~r than the atria1 Rutte: rate) could zm easily 
transiently entrain as interrupt the atrial flutter (S,ll,l8,?Rt. 
Also, it, that study (21). pacing ofatrial Rutte: was performed 
the ~elecl~on of atrial pacmg rates and appropriate duration of 
alnnl pacmg at the selected rates has been a problem in 
vinually 811 previous atrkal flutter pacing rtudier. 
The preten, study. by QXil@ the atria et a large variery of 
raies tmcreasmgly rapid ra,es in a ctcpwix fahion to the 
pomt ofa IranGem. unstable atrial rhythmjand by pacing fur 
et least I5 F. addressed the aforementioned concerns and 
lhmitmmns of the previous studio. Thub. the prcsmt study 
Qcnmtr a fair comparison. in each ptient studied. of the 
efficacy of alrial pacing conversion of atrial Autler to smus 
rhythm before and after administration of a drug. in this case 
procainam!de. Each patient served as his or her own control. 
The data clearly showed that procainamide admiGr,ratiou 
ueatlv enhances the effcacv of this lherrw and SU~CCS, that 
admmistration of mtraven&s procainamide toqciier wirh 
rapld atrial pacing is a safe and ci?cc,ive meanb of intC~UQl- 
ing atrial flutter and obtaining sinus rhythm. 
Clinical implications. Recently. Wyndham et II. (7) de- 
scribed a pat& with recuren,; sus&ed strial flutter in 
whom a radmfrequcncy itfrml pacemaker was implanted. 
allowing self-initiated conversion of atrial Autler by npid 
atrial stimulation. In this patient. procainamide potentiated 
pacing conversion of induced atrial Rutler to %ms rhythm 
and prevented sustained atrial fibrillation. Their report (7) is 
in agreement with our data and analysis of previous data 
~“---+-M--------l_-----+J 
Figure 6. Palient 8. Same recurdings a5 an Figsrc 3. After proeain- 
amide infeaion. high right atrial pacirb (cycle length 100 ms) 
ab”,Q,ly i”te‘r”Q,s alriat flutter wi,h QV,“,Qt rer”n;W,” Of “Or”,%, 
mms rhythm. Pacing before pracainamide infusion did not interrapt 
amal flutter. Abbreviations as in Figure 3. a and v represent nlripl 
dnd ventricular clcctrogramr. respeclivdy. See text fardkcursmn. 
(1%17.19) in which atrial pacing therapy to interrupt atrial 
fluaer and restore sinus rhythm had a high degree ofefkocy 
in patients who were receiving a !ypc IA antiarrhythmic 
drug. Thus, we suggest lb&, for patients with recurrent atrial 
Rutkr being trealed with an antkachycardia pacing device or 
for patients with a sudden episode ofatrial flutter that will be 
treated with temporary rapid atria.1 pacing. the addition of a 
type IA antiarrhythmic agenl Lo augment the cficacy of 
pacing conwrsion of atrial flutter to sinus rhythm should 
atways be considered. 
Finally, as we have previously summarized (12.28). rapid 
atrial pacing should always be able to inlerrupt atria! flutter 
whether or not the patient is receiving a type IA aotixrhyth- 
mic agent provided the atria are paced at a sufficiently rapid 
rate, for a sufficiently long enough period and with a strong 
enough stimulus to capture the atria. However, the precipi- 
taGon of atrial fibrillation was included RS successful inter- 
ruption of &al tlutter. This was considered a successful 
response not only because alrial Ruller wab terminated. but 
also because the ventricular response rate war much easier 
to conlrol during atrial fibrillation. Also, in many previous 
reports (1&12,16,18,19) that included a hiih percentage of 
patients in the period immediately after open heafl surgery. 
atria1 fibrillalion with a satisfactory venhkdar rate was 
considered an acceptable temporary thenpeulic end point. 
Moreover, atrial fibrillation in these latter patients was 
gencrall, transicnl. ultimalcly convening to sinus rhythm. 
However, particularly for patients such as those in our study 
whose atrial flutter occun outside the immediate period after 
open heart surgery, our data clearly indicate thal adminis- 
tration of a type IA anliarrhythmic agent should faeilitatc 
achievement of prompt and reliable conversion of atrial 
flutter to sinus rhythm. 
